iShares Biotechnology ETF (NASDAQ:IBB) Position Cut by Fernwood Investment Management LLC

Fernwood Investment Management LLC trimmed its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 8.2% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 3,873 shares of the financial services provider’s stock after selling 346 shares during the quarter. Fernwood Investment Management LLC’s holdings in iShares Biotechnology ETF were worth $526,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in IBB. Glass Jacobson Investment Advisors llc increased its holdings in shares of iShares Biotechnology ETF by 150.6% during the third quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 122 shares during the period. Values First Advisors Inc. acquired a new position in iShares Biotechnology ETF during the fourth quarter worth about $43,000. Horizon Bancorp Inc. IN acquired a new position in iShares Biotechnology ETF during the third quarter worth about $44,000. Tennessee Valley Asset Management Partners acquired a new position in iShares Biotechnology ETF during the fourth quarter worth about $44,000. Finally, Column Capital Advisors LLC acquired a new position in iShares Biotechnology ETF during the third quarter worth about $49,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Trading Up 1.5 %

IBB traded up $1.88 during trading on Monday, reaching $128.37. The company had a trading volume of 1,761,053 shares, compared to its average volume of 1,795,517. The firm’s 50-day simple moving average is $134.12 and its 200 day simple moving average is $129.88. iShares Biotechnology ETF has a 12-month low of $111.83 and a 12-month high of $141.16.

iShares Biotechnology ETF Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were paid a $0.126 dividend. The ex-dividend date was Thursday, March 21st. This represents a $0.50 dividend on an annualized basis and a yield of 0.39%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.